Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-02

Clinical Trial Update: Nebivolol, Lifestyle Modification and Arterial Stiffness [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating nebivolol with lifestyle modification for arterial stiffness in hypertension; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYSTOLIC (nebivolol hydrochloride)

Snippet

Sponsor: Virginia Polytechnic Institute and State University | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2016-03-02